medigraphic.com
Colegio de Medicina Interna de México.

2006, Number 6

<< Back Next >>

Med Int Mex 2006; 22 (6)

Cardiovascular risk factors in the urban female population of Mexico. FRIMEX IIa study

Lara EA, Meaney E, Ceballos RGM, Asbun BJ, Ocharán HME, Núñez SM, Meaney A, Velázquez MÒ, Verdejo PJ, Uribe P, Tapia CR

Language: Spanish
References: 34
Page: 484-492
PDF size: 412.92 Kb.


ABSTRACT

Background: The fast epidemiological transition that occurred in Mexico for several decades has increased the importance of the chronic-degenerative diseases, particularly, those of cardiovascular origin. Factors as the systemic arterial hypertension, hypercolesterolemia, smoking, disglucemic condition and obesity are determinants of cardiovascular illness.
Objective: To know the cardiovascular risk factors, obesity, hypertension arterial, diabetes and hypercholesterolemia of the Mexican women.
Participants and methods: 164,656 female patients recruited in a growing epidemiological survey, aged 20-80, were studied. The sample was formed by 140,017 individuals, aged 44 ± 13 years and with a gender distribution of 42% men and 58% women, from six Mexican cities (Mexico City, Guadalajara, Monterrey, Puebla, Leon and Tijuana). The frequencies of obesity, hypertension, smoking, total cholesterol and glucose in capillary blood, were estimated.
Results: Obesity or overweight was found in 71.9% of the participants. Hypertension was found in 26.5% of them, and the proportions of awareness, treatment and control for this disease were 49.3, 73 and 36%, respectively. Prevalence of hypertension increased with age, it was higher in men younger than 60 years old, but in more aged individuals was higher in women. Hypercholesterolemia was found in 40% of the persons, and cholesterolemia ≥240 mg/dL was significantly higher in women; 35.5% of men and 18.1% of women smoked. In 10.4% of participants was found diabetes mellitus type 2. There were significant Pearson’s correlations between body mass index and blood pressure; hypertension and glucose levels, and hypertension and total cholesterol concentrations.
Conclusion: It is concluded that this population faces a high cardiovascular risk profile, and a great probability of the occurrence of metabolic syndrome.


REFERENCES

  1. Estadísticas de mortalidad en México: muertes registradas en el año 2003. Dirección General de Información en Salud. Secretaría de Salud, México. Salud Publica Mex 2005;47;171-87.

  2. Lara A, Gaxiola S, Meaney-Mendiolea E. Epidemiología. En: Meaney-Mendiolea E, Cantú-Brito Carlos G, Gaxiola E, Arauz A, editores. Recomendaciones del grupo mexicano Interdisciplinario para el Estudio de la Aterotrombosis. Gac Med Mex 2006;142 (suppl 1):S1-S9.

  3. Lieberman IS. Evolutional genetics and diseases of civilization. J Evol Biochem Physiol 2003;41:233-9.

  4. Posadas Romero C, Sepúlveda J, Tapia Conyer R, Magos C, et al. Valores de colesterol sérico en la población mexicana. Salud Publica Mex 1992;34:157-67.

  5. Dirección General de Epidemiología, Secretaría de Salud. Encuesta Nacional de Enfermedades Crónicas, 1994.

  6. Dirección General de Epidemiología, Secretaría de Salud. Encuesta Nacional de Adicciones, México, DF, 1998.

  7. Velázquez Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelín Hernández G, Grupo ENSA 2000, Attié F, et al. Hipertensión arterial en México. Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2002;72:71-84.

  8. Rosas Peralta M, Lara Esqueda A, Pastelín Hernández G, et al. Re-encuesta Nacional de Hipertensión Arterial (RENAHTA): consolidación mexicana de los factores de riesgo cardiovascular. Cohorte nacional de seguimiento. Arch Cardiol Mex 2005;75:96-111.

  9. Lara A, Rosas M, Pastelín G, Aguilar C, Attié F, Velásquez Monroy O. Hipercolesterolemia e hipertensión arterial en México. Consolidación urbana actual con obesidad, diabetes y tabaquismo. Arch Cardiol Mex 2004;74:231-45.

  10. Meaney E, Lara-Esqueda A, Vela A, Martínez-Marroquín Y, López V, Meaney A, et al. Hipertensión arterial y otros factores de riesgo cardiovascular en una muestra de población de seis ciudades mexicanas. El estudio FRIMEX. En prensa.

  11. Velásquez Monroy O, Lara Esqueda A, Tapia Olarte F, Romo López L, Carrillo Toscano J, Colín Cario M. Medidas clínicas y antropométricas en el adulto y el adulto mayor. Manual de procedimientos para las mediciones. Programa de salud del adulto y el anciano. México: Secretaría de Salud, 2004;p:33.

  12. Secretaría de Salud. Norma Oficial Mexicana NOM-030-SSA2-1999 para la prevención, tratamiento y control de la hipertensión arterial.

  13. American Heart Association. Recommendations for human blood pressure determination by sphygmomanometers. Report of a special task force appointed by the steering committee. Circulation 1988;77:501B-514B.

  14. Hernández y Hernández H, Meaney Mendiolea E, Skromne Kadlubik D. Estudio del hipertenso. Historia clínica. Exámenes de laboratorio y gabinete. En: Hernández y Hernández H, Meaney Mendiolea E, Navarro Robles J, editores. III Consenso Nacional de Hipertensión Arterial Sistémica. Rev Mex Cardiol 2005;16:15-18.

  15. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.

  16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28(suppl 1):S37-S42.

  17. Secretaría de Salud. Norma Oficial Mexicana NOM-015-SSA2-1994 para la prevención, tratamiento y control de la diabetes.

  18. Grundy SM, Balady GJ, Criqui MH, Fletcher G, et al. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. Circulation 1997;95:2329-31.

  19. Smith SC Jr., Blair SN, Bonow RO, Brass LM, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2001;38:1581-3.

  20. Velásquez Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelin Hernández G, Grupo ENSA 2000, Sánchez-Castillo C, et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Inst Cardiol Mex 2003;73:62-77.

  21. Rivera JA, Barquera S, Campirano F, Campos I, Safdie M, Tovar V. Epidemiological and nutritional transition in México: Rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr 2002;5 (1A):113-22.

  22. Sánchez Castillo CP, Velázquez Monroy O, Berber A, Lara Esqueda A, Tapia Conyer R, James WP, et al. Anthropometric cutoff points por predicting chronic diseases in the Mexican National Survey 2000. Obes Res 2003;11:442-51.

  23. Khaodhiar L, McCowen KC, Blackburn GL. Obesity and its comorbid conditions. Clin Cornerstone 1999;2:17-31.

  24. Webber J. The comorbidities of obesity. Pract Diabetes Int 2001;18:293-96.

  25. Uwaifo GI. Obdesity. eMedicine. www.emedicine.com/med/topic 1653.htm (agosto 15, 2006).

  26. Meaney E, Samaniego V, Soltero E, González V, et al. Vascular dynamics in isolated systolic arterial hypertension. Clin Cardiol 1993;16:614-8.

  27. Olutade B, Hall WD. Systolic hypertension in the elderly. Curr Probl Cardiol 1997;22:405-48.

  28. Aguilar Salinas CA, Rojas R, Gómez Pérez FJ, García E, et al. Prevalence and characteristics of early-onset type 2 diabetes in Mexico. Am J Med 2002;113:569-74.

  29. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Valles V, Rios-Torres JM, Franco A, et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res 2004;35:76-81.

  30. Secretaría de Salud. Norma Oficial Mexicana NOM-174-SSA1-1998 para el tratamiento de la obesidad.

  31. World Health Organization. Physical status: the use and interpretation of anthropometry. Geneva. WHO 1995. WHO Technical Report No.854.

  32. Wood D, De Backer G, Faegerman O, Graham I, Mancia G, Pyörälä. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other societies on coronary prevention. Eur Heart J 1998;19:1434-503.

  33. Lara Esqueda A, González Chávez A, Amancio Chassin O, Arceo Guzmán M, et al. Herramientas para predecir el riesgo de enfermedades crónicas no transmisibles: un análisis más del estudio de las seis ciudades en México. Med Int Mex 2005;21:266-72.

  34. Sánchez Castillo CO, Velásquez Monroy O, Lara Esqueda A, Sepúlveda J, Tapia Conyer R, James WP. Diabetes and hypertension increases in a society with abdominal obesity-results of the Mexican National Health Survey 2000. Public Health Nutr 2005;8:53-60.




2020     |     www.medigraphic.com